Literature DB >> 10359106

The origin of marginal zone B cells in the rat.

P M Dammers1, N K de Boer, G J Deenen, P Nieuwenhuis, F G Kroese.   

Abstract

The marginal zone is a unique compartment that is only found in the spleen. Rat marginal zone B cells (MZ-B) can be distinguished from other B cells, e.g. recirculating follicular B cells (RF-B), by several phenotypic characteristics. Typically MZ-B cells are surface (s)IgMhi, sIgDlo and CD45R(B220)lo, whereas RF-B cells are sIgMlo, sIgDhi and CD45Rhi. In addition, MZ-B cells stain strongly with HIS57, a newly developed monoclonal antibody. The developmental pathway and origin of MZ-B cells are not exactly known. However, previous studies indicate that recirculating (i. e. thoracic duct) B cells can give rise to MZ-B cells. Here the origin of (naive) MZ-B cells was studied using adriamycin (doxorubicin)-induced B cell depletion. Using three-color flow cytometry and immunohistology we show that 2 days after a single i.v. injection of the anti-tumor drug adriamycin only RF-B cells can be detected, while all other B cell subpopulations are depleted, including all bone marrow precursor B cells. By studying the sequential reappearance of various B cell subsets and their precursors after adriamycin administration we show that MZ-B cells and the splenic marginal zone can be detected at a time point at which newly generated B cells (immature B cells) are not yet present. Given the observation that only RF-B cells were present at this time, we conclude that RF-B cells are the immediate MZ-B precursor cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359106     DOI: 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  After chemotherapy, functional humoral response capacity is restored before complete restoration of lymphoid compartments.

Authors:  A Zandvoort; M E Lodewijk; P A Klok; M A Breukels; G T Rijkers; W Timens
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 2.  Heterogeneity of Memory Marginal Zone B Cells.

Authors:  Jacobus Hendricks; Nicolaas A Bos; Frans G M Kroese
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

3.  Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10.

Authors:  Hamida Hammad; Matthias Vanderkerken; Philippe Pouliot; Kim Deswarte; Wendy Toussaint; Karl Vergote; Lana Vandersarren; Sophie Janssens; Ioanna Ramou; Savvas N Savvides; Jody J Haigh; Rudi Hendriks; Manfred Kopf; Katleen Craessaerts; Bart de Strooper; John F Kearney; Daniel H Conrad; Bart N Lambrecht
Journal:  Nat Immunol       Date:  2017-01-09       Impact factor: 25.606

Review 4.  Human spleen microanatomy: why mice do not suffice.

Authors:  Birte S Steiniger
Journal:  Immunology       Date:  2015-07       Impact factor: 7.397

5.  Slow recovery of follicular B cells and marginal zone B cells after chemotherapy: implications for humoral immunity.

Authors:  A Zandvoort; M E Lodewijk; P A Klok; P M Dammers; F G Kroese; W Timens
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

6.  Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

Review 7.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

Review 8.  B-cell antigen-receptor signalling in lymphocyte development.

Authors:  Leo D Wang; Marcus R Clark
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

9.  A semi-physiological-based pharmacokinetic/pharmacodynamic model to describe the effects of topotecan on b-lymphocyte lineage cells.

Authors:  Nieves Vélez de Mendizábal; Iván Martínez-Forero; María J Garrido; Eva Bandrés; Jesús García-Foncillas; Cristina Segura; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2010-01-26       Impact factor: 4.200

10.  B cell clones that sustain long-term plasmablast growth in T-independent extrafollicular antibody responses.

Authors:  Mei-Chi Hsu; Kai-Michael Toellner; Carola G Vinuesa; Ian C M Maclennan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.